MIAMI, May 26, 2015 /PRNewswire/ — Sanomedics, Inc. (OTC: SIMH) an international medical technology company today announced that it has expanded into the fast growing behavioral health sector with the strategic acquisition of Zen Charts. Zen Charts is a developmental stage, Software as a Services (SaaS) provider, specialized in Electronic Health Records (“EHR”) focused on addiction treatment service and care centers.

“The strategic acquisition of Zen Charts will position Sanomedics to enter the nascent behavioral health sector where the number of treatment service and care centers count in the tens of thousands domestically,” stated Keith Houlihan, President and Founder of Sanomedics, Inc. “Zen Charts develops cutting edge, cloud-based electronic healthcare records that enable healthcare facilities to reduce costs, maximize profits, while eliminating errors and improving comprehensive care for patients.”

“This acquisition marks an important milestone in the evolution of our growth strategy as this allows Sanomedics to target the $22.5 billion dollar EHR market according to Accenture. We view this as a very exciting development for Sanomedics and we are looking forward to commercializing the technology Zen Charts has developed,” concluded Keith Houlihan.

About Sanomedics, Inc.
Sanomedics, Inc. (OTC: SIMH) is an international medical technology company focused on developing, manufacturing, and acquiring cutting-edge technology, products and services. The Company operates mainly through its subsidiary, Thermomedics, which is dedicated to engineering, marketing and selling the Caregiver TouchFree™ Infrared thermometer. The Caregiver non-contact thermometer is FDA-cleared in the United States for clinical use by medical professionals. The Caregiver provides an accurate and expedited temperature reading without direct contact between patient and medical professional. Sanomedics has established an extensive distribution network with several leading healthcare supply chain providers to increase adoption of the Caregiver device within the medical community worldwide.

Forward Looking Statements
Statements in this press release regarding Sanomedics that are not historical facts are forward- looking statements and are subject to risks and uncertainties that could cause actual future events or results to differ materially from such statements. Any such forward-looking statements, including, but not limited to, financial guidance are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not directly or exclusively relate to historical facts. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “projects,” “forecasts,” “predicts,” “potential,” or the negative of those terms, and similar expressions and comparable terminology. These include, but are not limited to, statements relating to future events or our future financial and operating results, plans, objectives, expectations and intentions. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these expectations may not be achieved. Forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to known and unknown risks, uncertainties and other factors outside of our control that could cause our actual results, performance or achievement to differ materially from those expressed or implied by these forward-looking statements.

These forward-looking statements represent our estimates and assumptions only as of the date of this release and, except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this release. Given these uncertainties, you should not place undue reliance on these forward-looking statements and should consider various factors, including the risks described, among other places, in our most recent Annual Report on Form 10-K and in our Quarterly Reports on Form 10-Q, as well as any amendments thereto, filed with the SEC.

Investor Contacts:
Phil Carlson / Elizabeth Barker
KCSA Strategic Communications
212-896-1233 / 212-896-1203
pcarlson@kcsa.com / ebarker@kcsa.com

Media Contacts:
Chloe Font / Andrew Herweg
KCSA Strategic Communications
212-896-1287 / 212-896-1273
cfont@kcsa.com / aherweg@kcsa.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sanomedics-targeting-behavioral-health-and-electronic-health-records-with-strategic-acquisition-of-zen-charts-300088413.html

SOURCE Sanomedics, Inc.